PMID- 21352425 OWN - NLM STAT- MEDLINE DCOM- 20110623 LR - 20111117 IS - 1399-5448 (Electronic) IS - 1399-543X (Linking) VI - 12 IP - 2 DP - 2011 Mar TI - Does the relative risk for type 1 diabetes conferred by HLA-DQ, INS, and PTPN22 polymorphisms vary with maternal age, birth weight, or cesarean section? PG - 91-4 LID - 10.1111/j.1399-5448.2010.00669.x [doi] AB - BACKGROUND AND OBJECTIVE: Maternal age at birth, birth weight, and cesarean section has been associated with a weak but significant increase in risk of type 1 diabetes. The objective was to assess whether the relative risk for type 1 diabetes conferred by established susceptibility loci human leukocyte antigen (HLA)-DQ, INS, and PTPN22 differed depending on these perinatal factors. METHODS: We employed a case-control study with 456 cases of type 1 diabetes diagnosed before 15 yr of age and 1377 population-based control children. HLA genotypes were divided into high to moderate risk (DQ8/DQ2, DQ8/DQ8, DQ8/X, DQ2/DQ2) vs. all other genotypes. Case-only analysis using logistic regression was used to test for significant interaction. RESULTS: There was no significant difference in the relative risks conferred by HLA-DQ, INS, or PTPN22 by maternal age, birth weight, or mode of delivery, except the relative risk conferred by PTPN22 which was 2.11 [95% confidence interval (CI): 1.64-2.72] for those born vaginally and 0.99 (95% CI: 0.50-1.99) for those born by cesarean section [p(interaction) = 0.028]. CONCLUSION: The relative risks conferred by the three established susceptibility genes investigated here were independent of the perinatal factors, apart from a possible interaction between PTPN22 and mode of delivery. CI - (c) 2010 John Wiley & Sons A/S. FAU - Stene, Lars C AU - Stene LC AD - Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway. lars.christian.stene@fhi.no FAU - Ronningen, Kjersti S AU - Ronningen KS FAU - Undlien, Dag E AU - Undlien DE FAU - Joner, Geir AU - Joner G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100906 PL - Denmark TA - Pediatr Diabetes JT - Pediatric diabetes JID - 100939345 RN - 0 (HLA-DQ Antigens) RN - 0 (Insulin) RN - EC 3.1.3.48 (PTPN22 protein, human) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatase, Non-Receptor Type 22) SB - IM MH - Birth Weight/genetics/*physiology MH - Case-Control Studies MH - *Cesarean Section MH - Child MH - Diabetes Mellitus, Type 1/*etiology/genetics MH - Female MH - Genetic Predisposition to Disease/etiology MH - HLA-DQ Antigens/*genetics MH - Humans MH - Infant, Newborn MH - Insulin/*genetics MH - Male MH - *Maternal Age MH - *Polymorphism, Genetic/physiology MH - Pregnancy MH - Protein Tyrosine Phosphatase, Non-Receptor Type 22/*genetics MH - Risk EDAT- 2011/03/01 06:00 MHDA- 2011/06/24 06:00 CRDT- 2011/03/01 06:00 PHST- 2011/03/01 06:00 [entrez] PHST- 2011/03/01 06:00 [pubmed] PHST- 2011/06/24 06:00 [medline] AID - 10.1111/j.1399-5448.2010.00669.x [doi] PST - ppublish SO - Pediatr Diabetes. 2011 Mar;12(2):91-4. doi: 10.1111/j.1399-5448.2010.00669.x. Epub 2010 Sep 6.